Age, Biography and Wiki
Peter S. Kim was born on 1 April, 1958. Discover Peter S. Kim's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 65 years old?
| Popular As | Peter S. Kim |
| Occupation | N/A |
| Age | 65 years old |
| Zodiac Sign | Aries |
| Born | 1 April, 1958 |
| Birthday | 1 April |
| Birthplace | N/A |
| Nationality |
We recommend you to check the complete list of Famous People born on 1 April. He is a member of famous with the age 65 years old group.
Peter S. Kim Height, Weight & Measurements
At 65 years old, Peter S. Kim height not available right now. We will update Peter S. Kim's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family | |
|---|---|
| Parents | Not Available |
| Wife | Not Available |
| Sibling | Not Available |
| Children | Not Available |
Peter S. Kim Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Peter S. Kim worth at the age of 65 years old? Peter S. Kim’s income source is mostly from being a successful . He is from . We have estimated Peter S. Kim's net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Peter S. Kim Social Network
Timeline
During his tenure, Merck gained approval of more than 20 new medicines and vaccines. These include Januvia (the first DPP-4 inhibitor for type 2 diabetes), Gardasil (the first vaccine for prevention of cervical cancer), Isentress (the first HIV integrase inhibitor), Zostavax (the first vaccine for the prevention of shingles in adults), and Rotateq (an oral vaccine for the prevention of rotavirus infection in infants). He also led the biomarker-based development of Keytruda. In 2013, he retired from Merck and was succeeded by Roger Perlmutter. He was appointed to the faculty at Stanford University in 2014.
Peter S. Kim is an American scientist. He was president of Merck Research Laboratories (MRL), 2003-2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.
Kim joined Merck Research Laboratories (MRL) in 2001 as executive vice president, Research and Development. He was promoted to president in January 2003. In this role Kim oversaw all of Merck's drug and vaccine research and development activities.
Kim is of Korean descent. Kim grew up in Ridgewood, New Jersey the son of a single mother, and his first job was in 1974 at a Roy Rogers restaurant, where he earned money to pay for college. Kim earned his A.B. in chemistry at Cornell University in 1979 where he conducted research with the late George P. Hess. He received his Ph.D. in Biochemistry at Stanford University under the guidance of Robert L. ("Buzz") Baldwin.
